A Phase 4 interventional study of NSAID capsules and Opioid capsule in Pain, Postoperative and Osteoarthritis Thumb, sponsored by Stanford University. Terminated at 2 sites in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by Stanford University · Phase 4, Interventional, and Treatment
Study drug supply unavailable
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative — 22 open to participants now, 25 under way, 3 of them phase 3. A drug class: Anti-Inflammatory Agents, Non-Steroidal · Pain, Postoperative.
Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, this one is the 140th largest by enrollment, is one of 18 that started in 2021, is one of 84 in phase 4, and was the 160th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →22 of the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative are open now, in 8 countries. Recruiting first, the newest first:
Moumtzidou Maria Aikaterini · Sites in Greece
Ages 18+ · Women only
Northwestern University · Sites in United States
Ages 18–80
University of Puerto Rico · Sites in Puerto Rico
Ages 21–65
Jessica D. Kresowik · Sites in United States
Ages 18–37 · Women only
University of Oklahoma · Sites in United States
Ages 18–110
By country, each count listing its studies:
A class of medicines: which ones, and the studies of each, are on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 45 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
229 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 40 · Phase 3 56 · Phase 4 84
First in 2000; this study’s year is marked. 18 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 73 is close to the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 229 interventional studies. Of the 168 that completed or were terminated, 70 (42%) have results posted.
This tab as a report to print or save as PDF → With an account.
55 of 229 have an industry lead sponsor. The 10 most frequent:
Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
25 studies in Pain, Postoperative by Stanford University: 8 open now, 8 under way, none of them phase 3. Of 13 finished, 5 (38%) have results posted.
Among the 25 studies in Pain, Postoperative by Stanford University, this one is the 9th largest by enrollment of the 23 interventional ones that give a count, is one of 6 that started in 2021, is one of 6 in phase 4, and was the 16th registered.
Stanford University’s Pain, Postoperative studies by the year they started, since 2007.
12 of the studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03823534Phase 3St. Louis UniversityPost-Op Pain Control for Prophylactic Intramedullary Nailing. | 2027-03-31 |
| NCT07047040Phase 3Assiut UniversityAnalgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin | 2027-10-30 |
| NCT07571252University of Puerto RicoImpact of Preemptive Analgesia on Postoperative Pain in Orthognathic Surgery | 2026-12 |
| NCT05919745Marquette UniversityPreemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft | 2026-12 |
| NCT06379425Northwell HealthImpact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries | 2027-01-01 |
Add all 12 to your calendar (.ics) → With an account.
Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, from their registry updates:
Among Stanford University’s 25 in Pain, Postoperative:
This tab as a report to print or save as PDF → With an account.
In the US, pain management after surgery for surgical treatment of osteoarthritis at the base of the thumb typically consists of prescription opioids during the early recovery phase. Given the highly addictive nature of prescription opioids, guidelines are being evaluated by hand surgeons to reduce opioid use while still maintaining pain control after surgery. A promising approach is to use non-narcotic medication as the first line of treatment. The purpose of this study is to demonstrate the efficacy of a combination of non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen and acetaminophen, in comparison to a morphine analogue substance (oxycodone) for pain management in the first 30 days after surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
English proficient,
Exclusion Criteria:
Current use of opioids
Concurrent surgeries (ex. trapeziectomy combined with carpal tunnel release)
Inability to complete study forms (education, cognitive ability, mental status, medical status)
Allergy or intolerance to Ibuprofen, Acetaminophen and/or Oxycodone
Liver or kidney dysfunction, abnormal liver enzymes restricting use of acetaminophen or ibuprofen
History of chronic heart failure, upper gastrointestinal bleeding or coagulopathy
History of complex regional pain syndrome
Following surgery will receive NSAID capsules following surgery. Will take online and phone surveys.
Drug: NSAID capsules
Following surgery will receive opioid capsules following surgery. Will take online and phone surveys.
Drug: Opioid capsule
1, Ibuprofen 400-mg and 1, Acetaminophen 500-mg capsule per dosage
1, Oxycodone 5-mg capsule and 1, placebo capsule per dosage
Change of medication consumption and overall amount
The number of capsules consumed in the last 24 hours. Consumption rate and overall consumption will be compared between groups to assess efficacy and inform further statistical analyses.
Time frame: Every day from the first day after surgery to 30 days post-op.
Change of worst daily pain score measured over time
Numerical score describing surgical pain at its worst in the last 24 hours, between 1 and 10, 1 being no pain, 10 being the worst possible pain.
Time frame: Every day from the first day after surgery to 30 days post-op.
Change of least daily pain score measured over time
Numerical score describing surgical pain at its least in the last 24 hours, between 1 and 10, 1 being no pain, 10 being the worst possible pain.
Time frame: Every day from the first day after surgery to 30 days post-op.
Change of average daily pain score measured over time
Numerical score describing average surgical pain in the last 24 hours, between 1 and 10, 1 being no pain, 10 being the worst possible pain.
Time frame: Every day from the first day after surgery to 30 days post-op.
Change in Quick DASH scores over time
Quick Disabilities of the Arm, Shoulder, and Hand (qDASH) is a responsive measure to patient-reported functional change in the hand and upper extremity patient population, ranging from 0 to 100. Lower scores signify limited function and increased pain.
Time frame: Baseline, Post-operative weeks 1, 3, 5, and 8
Change in PROMIS-PI scores over time
PROMIS-PI scores (Patient-Reported Outcomes Measurement Information System - Pain Interference) are effective measures of the change in perceived pain, supporting intervention related studies assessing power analyses for comparative research. We use the Pain Interference - Short Form version 6b, which consists of 6 questions regarding how much the pain experienced in the last 7 days interfered with everyday aspects of life (i.e. enjoyment, ability to concentrate, day to day activities, recreational activities, doing tasks away from home, and socializing with others). The answers to all questions are ordinals ranging from 1 (not interfered at all) to 5 (interfered very much).
Time frame: Baseline, Post-operative weeks 1, 3, 5, and 8
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2021 to primary completion in Jun 2026, 53 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: primary completion Feb 2027 → Jun 2026 and completion Aug 2027 → Jun 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Study drug supply unavailable
Study drug supply unavailable
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is terminated, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Anti-Inflammatory Agents, Non-Steroidal · Opioids